MHM Magazine

S6 MEDIKINET MR 5 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 5 mg. Reg.No. 51/1.2/1088. S6 MEDIKINET MR 10 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 10 mg. Reg.No. 51/1.2/1089. S6 MEDIKINET MR 20 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 20 mg. Reg.No. 51/1.2/1090. S6 MEDIKINET MR 30 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 30 mg. Reg.No. 51/1.2/1091. S6 MEDIKINET MR 40 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 40 mg. Reg.No. 51/1.2/1092. S6 MEDIKINET MR 50 mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 50 mg. Reg.No. 51/1.2/1093. S6 MEDIKINET MR 60mg capsules. Each modified-release capsule contains methylphenidate hydrochloride 60 mg. Reg.No. 51/1.2/1094. For full prescribing information refer to the professional information approved by the Medicines Regulatory Authority. (PI 11/2021). Marketed by Adcock Ingram Limited. Co. Reg. No. 1949/034385/06. Private bag X 69, Bryanston, 2021, South Africa. Customer Care:0860 ADCOCK/232625. www.adcock.com. 202407111016625 November 2024. Unique MPH delayed release pellet system for rapid onset of action and sustained efficacy (up to 8 hours) throughout the academic or working day 1,2 References: 1. García-García P, López-Muñoz F, Molina JD, et al. Methylphenidate Extended-Release Capsules: A New Formulation for Attention-Deficit Hyperactivity Disorder. Frontiers in Drug Design & Discovery 2009;4:228- 246. 2. Medikinet MR package insert. MC Pharma (Pty) Ltd; South Africa. August 2021. 3. Döpfner M, Gerber WD, Banaschewski T, et al . Comparative efficacy of once-a-day extendedrelease methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adol Psych 2004;12(1):93-101. 4. Schulz E, Fleischhaker C, Henninghausen K, et al . A Double-Blind, Randomized, Placebo/Active Controlled Crossover Evaluation of the Efficacy and Safety of Ritalin LA in Children with Attention-Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting. J Child Adolesc Psychopharmacol 2010;20(5):377-385. 5. Phillipsen A, Jans T, Graf E, et al . Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder. A Randomized Clinical Trial. JAMA Psychiatry 2015;72(12):1199-210. 6. Rösler M, Retz W, Fischer R, et al . Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry 2010;11:709-718. 7. Retz W, Rösler M, Fischer R, et al . Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions. J Neural Transm (Vienna) 2020;127(10):1427-1434. In children and adolescents • Improves attention and behaviour in the classroom 3 • Improves academic perfomance 3 • Helps improve social interactions with peers 4 In adults • MPH provides long-term control of key symptoms of ADHD 5 • Improves emotional dysregulation and reactivity 6 • Improves social adaptiveness 7 Simple to dose: Capsule may be opened and pellets sprinkled onto a tablespoon. 2 A GOOD start to a GOOD day AHEAD IN ADHD methylphenidate hydrochloride